Given the constantly changing regulatory climate for biopharma, compliance specialists and regulatory officials have an unbelievable amount to be aware of and track. It ranges from development to clinical trials, to production and marketing. There are novel drugs, generics, biologics and now biosimilars. So what are the most pressing issues facing the industry?

Watch this webinar and get the information and guidance you need from our panel of regulatory specialists, compliance professionals and industry experts.